New molecule to improve pharmaceuticals draws inspiration from nature’s toolbox
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product...
List view / Grid view
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product...
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
Researchers synthesized self-assembling peptide amphile nanofibers that targeted areas of plaque and could be delivered by intravenous injection...
Engineers have developed a microfluidic system where more than ten thousand of these devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket...
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
A new drug could ease the distress of men and women who suffer from baldness...
Researchers have created a device that can quickly and inexpensively determine whether new pharmaceutical formulations have trace crystallinity...
Women who take certain antipsychotic medications and continue the use of these medications through pregnancy may be at increased risk for gestational diabetes...
A potential alternative to antibiotics, protein-coated beads block bacteria from binding host cells...
Topical treatment with live Roseomonas mucosa was found to be safe for adults and children with atopic dermatitis...
Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy...
Researchers have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer...
Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab...